7Zhang G,David A,Wiedmann TS. Performance of the vibrating membrane acrosol generation device:Aceroneb Micropump Nebulizer[J].JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG,2007,(04):408-416.
8Yeo LY,Friend JR,Mclntosh MP. Ultrasonic nebulization platforms for pulmonary drug delivery[J].Expert Opin Drug Deliv,2010,(06):663-679.
5Stafford RS.Regulating off-label drug use-rethinking the role of the FDA[J].N Engl J Med,2008,358(14):1427-1429.
6Fairman KA,Curtiss FR.Regulatory actions on the off-label use of prescription drugs:ongoing controversy and contradiction in 2009 and 2010[J].J Manag Care Pharm,2010,16(8):629-639.
7Wertheimer A.Off-label prescribing of drugs for children[J].Curr Drug Saf,2011,6(1):46-48.
8Shah SS,Hall M,Goodman DM,et al. Off-label use in hospitalized children[J].Arch Pediatr Adolesc Med,2007,161(3):282-290.
9Herring C,McManus A,Weeks A.Off-label prescribing during pregnancy in the UK:an analysis of 18,000 prescriptions in Liverpool Women's Hospital[J].Int J Pharm Pract,2010,18(4):226-229.
10Hames A.Unlicensed and off-label drug use in elderly people[J].Age And Ageing,2001,30(6):530-531.
